Clinical trials
Recruiting Hematologic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 10 |
| 2025 | 11 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing InnoCare Pharma Tech Co., Ltd. | 3 |
| Grit Biotechnology | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Ruijin Hospital | 2 |
| Shenzhen TargetRx Co., Ltd. | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| The First Affiliated Hospital of Xiamen University | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 43 |
| Recurrence | 7 |
| Leukemia, Myeloid, Acute | 5 |
| Multiple Myeloma | 5 |
| Lymphoma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Myelodysplastic Syndromes | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.